Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Edelman

Showing results (251-260 of 348) with videos related to

Pageof 35
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 25, 2009
Pemetrexed plus cetuximab in patients with recurrent non-small cell lung cancer (NSCLC): a phase I/II study from the Hoosier Oncology GroupShadia Jalal, David Waterhouse, Martin J Edelman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
Obatoclax mesylate, a pan-bcl-2 inhibitor, in combination with docetaxel in a phase 1/2 trial in relapsed non-small-cell lung cancerAlberto Chiappori, Charles Williams, Donald W Northfelt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2016
Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non-Small-Cell Lung Cancer: METLungDavid R Spigel, Martin J Edelman, Kenneth O'Byrne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Phase I study of tirapazamine plus cisplatin/etoposide and concurrent thoracic radiotherapy in limited-stage small cell lung cancer (S0004): a Southwest Oncology Group studyQuynh-Thu Le, Jason McCoy, Stephen Williamson, et al.
Lung Cancer (Amsterdam, Netherlands)|February 19, 2017
Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC)Vincent K Lam, Søren M Bentzen, Pranshu Mohindra, et al.
The Annals of Thoracic Surgery|January 28, 2010
Pneumonectomy for lung cancer after preoperative concurrent chemotherapy and high-dose radiationMark J Krasna, Ziv Gamliel, Whitney M Burrows, et al.
Journal of Public Health Medicine|July 27, 2001
Rating the appropriateness of coronary angiography, coronary angioplasty and coronary artery bypass grafting: the ACRE study. Appropriateness of Coronary Revascularisation studyH Hemingway, A M Crook, J R Dawson, et al.
International Journal of Radiation Oncology, Biology, Physics|February 19, 2008
Long-term survival in patients with synchronous, solitary brain metastasis from non-small-cell lung cancer treated with radiosurgeryTodd W Flannery, Mohan Suntharalingam, William F Regine, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 4, 2020
Alternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global PandemicSameera Kumar, Steven Chmura, Clifford Robinson, et al.
Clinical Lung Cancer|August 6, 2013
Chemotherapy outcomes by histologic subtypes of non-small-cell lung cancer: analysis of the southwest oncology group database for antimicrotubule-platinum therapyKaren Kelly, Kari Chansky, Philip C Mack, et al.
Pageof 35

Showing results (251-260 of 348) with videos related to

Sort By:
Pageof 35
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 25, 2009
Pemetrexed plus cetuximab in patients with recurrent non-small cell lung cancer (NSCLC): a phase I/II study from the Hoosier Oncology GroupShadia Jalal, David Waterhouse, Martin J Edelman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
Obatoclax mesylate, a pan-bcl-2 inhibitor, in combination with docetaxel in a phase 1/2 trial in relapsed non-small-cell lung cancerAlberto Chiappori, Charles Williams, Donald W Northfelt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2016
Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non-Small-Cell Lung Cancer: METLungDavid R Spigel, Martin J Edelman, Kenneth O'Byrne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Phase I study of tirapazamine plus cisplatin/etoposide and concurrent thoracic radiotherapy in limited-stage small cell lung cancer (S0004): a Southwest Oncology Group studyQuynh-Thu Le, Jason McCoy, Stephen Williamson, et al.
Lung Cancer (Amsterdam, Netherlands)|February 19, 2017
Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC)Vincent K Lam, Søren M Bentzen, Pranshu Mohindra, et al.
The Annals of Thoracic Surgery|January 28, 2010
Pneumonectomy for lung cancer after preoperative concurrent chemotherapy and high-dose radiationMark J Krasna, Ziv Gamliel, Whitney M Burrows, et al.
Journal of Public Health Medicine|July 27, 2001
Rating the appropriateness of coronary angiography, coronary angioplasty and coronary artery bypass grafting: the ACRE study. Appropriateness of Coronary Revascularisation studyH Hemingway, A M Crook, J R Dawson, et al.
International Journal of Radiation Oncology, Biology, Physics|February 19, 2008
Long-term survival in patients with synchronous, solitary brain metastasis from non-small-cell lung cancer treated with radiosurgeryTodd W Flannery, Mohan Suntharalingam, William F Regine, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 4, 2020
Alternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global PandemicSameera Kumar, Steven Chmura, Clifford Robinson, et al.
Clinical Lung Cancer|August 6, 2013
Chemotherapy outcomes by histologic subtypes of non-small-cell lung cancer: analysis of the southwest oncology group database for antimicrotubule-platinum therapyKaren Kelly, Kari Chansky, Philip C Mack, et al.
Pageof 35